Get started

Artelo Biosciences, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

ARTL chart

Key stats

Market capitalization
4.213MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.31USD
Net income
−10.083MUSD
Revenue
—
Shares float
2.859M
Beta
0.69

About Artelo Biosciences, Inc.

Sector
Health Technology
CEO
Gregory D. Gorgas
Headquarters
Solana Beach
Website
artelobio.com
Employees (FY)
7
Founded
2011
ISIN
US04301G5080

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.

Ideas

ARTL BULLISH SETUP %20 RETURNHello traders, I would like to share my new analysis that is ARTL. We are in a bullish flag pattern also retesting trendline and support. I have %20 aim while risking just %6. Please support this idea with like If you find it useful. The information given is not a financial advice. I'm just sharin
tradingview is a bitch making me re-write all this shitIndications & Patterns Monthly TF - Descending Wedge formed and being tested - EMA21 being tested with ATH volume Weekly TF - Heavily tested EMA21 and SMA50 broken and have crossed - SMA100 now being tested - Leaplong downtrend line forming descending triangle with fib 0 - Bullish Div on Sqzmom
$ARTL surged 92% on buy rating from Ladenburg analystArtelo Biosciences surged 92% on buy initiation from Ladenburg Shares of $ARTL Artelo Biosciences surged on friday after Ladenburg analyst Michael Higgins initiated the company with a buy rating. They give the biopharma a $7 price target. It also represents a potential 329% upside over the stock’s
$ARTL is gonna fall todayPupm&Dump trading strategy idea. $ARTL is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $2,15; stop-loss — $2,60; take-profit — $1,25; Do not view th
6

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
No revenue here
This company hasn't generated any revenue in the last financial year
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers